Komzifti (ziftomenib) - Kura Oncology, Kyowa Kirin
Venclexta (venetoclax) - Roche, AbbVie
Xospata (gilteritinib) - Astellas
Tibsovo (ivosidenib) - Servier
Vanflyta (quizartinib) - Daiichi Sankyo
Idhifa (enasidenib) - BMS, Servier
midostaurin - Generic mfg.
Revuforj (revumenib) - Syndax Pharma
Rezlidhia (olutasidenib) - Rigel Pharmaceuticals
https://www.sciencedirect.com/science/article/abs/pii/S2152265026018628
 
Arashdeep Singh MD 1; Sidharth Mahajan MD 2; Madho Mal MD 3; Shankar Biswas MD 4; Bhawarpreet Bhatti MBBS 5; Gurmanleen Sohi 6; Karanbir Purewal MBBS 7; Aniroodh Venugopalan MBBS 8; Shravani Katkam MBBS 9
 
Sep 1, 2026
 
Prev Next